once a month, dr peter lu bank cove is a dementia specialist with ucsf's memory and aging center at mission bay. the drug has been given to patients participating in the clinical trials conducted here. it certainly is a big paradigm shift for the field, and i'm excited about that. and, uh, we now have a disease modifying drug that the fda has approval monday was controversial. potential side effects include brain inflammation and bleeding. there are mixed results from the clinical trials and an independent panel of experts recommended against fda approval. it certainly is unusual to have a. fda approval. um with one negative andtive trs very exciting, and, uh, but we'll have to wait. it's the only way you can be realistic, right. the doctor says it will likely take a few months for the drug to be given to patients as a treatment. biogen the maker of the drug says it would charge $56,000 a year per patient without insurance in san francisco, amber. lee ktvu, fox two news lawmakers are focusing on a classified report from the lawrence livermore national lab as they look into the origins of th

peter lu is the chief scientific officer at the university of ottawa heart institute, and he began toice hard inflammation in patients who received the vaccine. it's more than coincidental, he said. in germany, authorities concluded the same thing. this is a serious development for us in the united states. statistical trends observed in israel hold here as many as 150,000 young americans will develop a potentially fatal heart disorder because the covered vaccines. that's not alarmism, it's not some kind of anti-vector conservancy theory, it's real. this afternoon the cdc confirmed what appears to be dangerous side effects. and the cdc's vaccine safety datalink, both so strikingly high rates of myocarditis and young people who have been vaccinated. we clearly have an imbalance there, the cdc official at official announced today. imbalanced is one way to put it, potential emergency is another. given these numbers it's possible that healthy young people in this country up would be much more likely to be harmed by the vaccine then by covid itself. that would be a disaster, that could be t

once a month, dr peter lu bank cove is a dementia specialist with ucsf's memory and aging center at mission bay. the drug has been given to patients participating in the clinical trials conducted here. it certainly is a big paradigm shift for the field, and i'm excited about that. uh we now have a disease modifying drug, but the fda is approval monday was controversial. potential side effects include brain inflammation and bleeding. there are mixed results from the clinical trials and an independent panel of experts recommended against fda approval. it certainly is unusual to have fda approval, um with with one negative and one positive trial, inspired at the institute of aging monday. mark the first day of in person programs resuming since the pandemic shut down the program director for dementia services says so far families of alzheimer patients have expressed optimism they have sort of said, where do i sign up? how soon can i get this? it's very exciting. and, uh, but we'll have to wait. it's the only way you can be realistic, right? the doctor says it will likely take a few months for t